Mexico’s Cofepris Reports Delays in COVID-19 Vaccine Authorization Process

Mexico’s Cofepris Reports Delays in COVID-19 Vaccine Authorization Process

The Federal Commission for the Protection against Health Risks (Cofepris) reported this Wednesday that the pharmaceutical companies that requested the health register of vaccines contra COVID-19 require more time to provide information to obtain authorization for your Commercial use. Through a statement, the regulatory authority pointed out that Pfizer SA de CVvaccine producer Comirnaty; y … Read more

Emergency Vaccination Wastage in Acapulco: Cofepris Secures 616 Vaccines, CFE Works at Forced Marches

Emergency Vaccination Wastage in Acapulco: Cofepris Secures 616 Vaccines, CFE Works at Forced Marches

The Federal Commission for the Protection against Sanitary Risks (Cofepris) during its inspections in Acapulco announced that 616 vaccines were secured that remained without refrigeration in the Tres Palos Unit of the port. You may be interested: Doctor gives consultations and medicines to victims of Hurricane Otis in Acapulco The local health services reported that … Read more

Alert: Counterfeit Hepatitis B Vaccine Circulating in Mexico City

Alert: Counterfeit Hepatitis B Vaccine Circulating in Mexico City

Mexico City. The Federal Commission for the Protection against Health Risks (Cofepris) issued an alert because it identified the circulation of a counterfeit vaccine, Provibac-B recombinant against Hepatitis B. It presents two different lot numbers: 2526211014-1 on the box and 566220/410- 2 on the bottle label. Also the expiration dates vary on both sites. It … Read more

Dengvaxia Vaccine Alert: Risks of Incorrect Usage in Children Under 9 Years of Age in Mexico City

Dengvaxia Vaccine Alert: Risks of Incorrect Usage in Children Under 9 Years of Age in Mexico City

Mexico City. The Dengvaxia® vaccine (Tetravalent live attenuated virus vaccine against dengue) is being applied to children under 9 years of age, alerted the Federal Commission for the Protection against Sanitary Risks (Cofepris), a body that issued a “notice” tonight risky”. He explained that it was detected that the biological is being applied by general … Read more

Cofepris Authorizes New Health Supplies: Influenza Vaccine, Medicines, and Medical Devices

Cofepris Authorizes New Health Supplies: Influenza Vaccine, Medicines, and Medical Devices

The Federal Commission for the Protection against Sanitary Risks (Cofepris) authorized the use of a high-dose, quadrivalent influenza vaccine, subtypes A and B, for people over 65 years of age. According to the last fortnightly Report on therapeutic expansion, it was detailed that among the new molecules that obtained sanitary registration, there is also an … Read more

“Mexico Approves Abdala Vaccine for Children 5 and Up with 92% Efficacy Against COVID-19”

“Mexico Approves Abdala Vaccine for Children 5 and Up with 92% Efficacy Against COVID-19”

Mexico City. The New Molecules Committee (CMN) of the Federal Commission for Protection against Sanitary Risks (Cofepris) issued a favorable opinion on the recombinant protein vaccine of the receptor binding domain of the SARS-CoV-2 virus, known as Abdala. The vaccine, developed by the Center for Genetic Engineering and Biotechnology (CIGB) of the Republic of Cuba, … Read more

Supreme Court Orders Transparent Documentation of Covid-19 Vaccine Authorization Process

Supreme Court Orders Transparent Documentation of Covid-19 Vaccine Authorization Process

The Supreme Court of Justice of the Nation (SCJN) ordered the Federal Commission for the Protection against Sanitary Risks (Cofepris) to make transparent all the documentation related to the authorization process of the vaccine against Covid-19 “CoronaVac”, manufactured by the Sinovac company. It is the first time that the highest court confirms a resolution of … Read more

Approval of Monotherapy for Advanced Breast Cancer by Cofepris.

Approval of Monotherapy for Advanced Breast Cancer by Cofepris.

blanca valadez Mexico City / 21.03.2023 18:43:56 The Federal Commission for the Protection against Sanitary Risks (Cofepris) approved the monotherapy developed in collaboration with Daiichi Sankyo, to care for people with HER2-positive and HER2-low advanced and metastatic breast cancer, who have received prior treatment, reported AstraZeneca Mexico. “With this innovative therapy, a new era begins … Read more